Exclusive Archives

Exclusive Matthew Herper and Lev Facher

White House to launch effort to develop next generation of Covid vaccines

Exclusive Lev Facher

Biden picks renowned cancer surgeon Monica Bertagnolli as NCI chief

Exclusive Lev Facher

In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans

Exclusive Ed Silverman

A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices

Exclusive Helen Branswell

Genetic data indicate at least two separate monkeypox outbreaks underway, suggesting wider spread

Exclusive Nicholas Florko

Senate FDA legislation will include dietary supplement, cosmetic reforms

Exclusive Nicholas Florko

Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs

Exclusive Rick Berke

Gates Foundation CEO has ‘zero expectation’ that Melinda French Gates will step down as co-chair after divorce

Exclusive Rachel Cohrs

White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process

Exclusive Ed Silverman

Justice Department probes Bausch Health over marketing for dermatology drugs

Exclusive Nicholas Florko

Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules

Exclusive Matthew Herper

Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments

Exclusive Lev Facher

NIH’s cancer chief, Ned Sharpless, to step down

Exclusive Lev Facher

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence

Exclusive Megan Molteni

New details emerge about a U.S. scientist’s obscured role in the ‘CRISPR babies’ scandal

Exclusive Lev Facher

Key lawmaker: ARPA-H won’t be part of NIH

Exclusive Nicholas Florko and Rachel Cohrs

More Democrats flag ‘questions,’ remain uncertain about Biden’s FDA pick, Robert Califf

Exclusive Casey Ross

He founded what became IBM’s most valuable health database. Now, he’s sounding an alarm about patient privacy

Exclusive Rachel Cohrs

The Biden administration used billions in hospital Covid-19 funds to pay drugmakers

Exclusive Damian Garde and Adam Feuerstein

With its Alzheimer’s drug in turmoil, Biogen eyes a list of potential acquisitions

Exclusive Eric Boodman

A tiny Florida company got more of a scarce Covid therapy than some big hospitals, raising equity questions

Exclusive Adam Feuerstein and Damian Garde

Moderna, Amgen among biotech heavyweights pulling out of JPM conference over Covid concerns

Exclusive Katie Palmer

‘A multi-decade journey’: Chan Zuckerberg Initiative invests another $3.4 billion to advance scientific tools

Exclusive Kate Sheridan

Flagship to launch a new startup focused on neurodegenerative conditions, including Parkinson’s

Exclusive Rachel Cohrs

Exclusive

Most Read

Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb

White House documents detail a looming squeeze on Covid-19 boosters

Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist

Inside the culture of fear in Eric Lander’s White House science office

The Catholic hospital system Ascension is running a Wall Street-style private equity fund

Inside ‘Project Onyx’: How Biogen used an FDA back channel to win approval of its polarizing Alzheimer’s drug

The Trump administration quietly spent billions in hospital funds on Operation Warp Speed

Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says

All Coverage

White House to launch effort to develop next generation of Covid vaccines

Biden picks renowned cancer surgeon Monica Bertagnolli as NCI chief

In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans

A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices

Genetic data indicate at least two separate monkeypox outbreaks underway, suggesting wider spread

Senate FDA legislation will include dietary supplement, cosmetic reforms

Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs

Gates Foundation CEO has ‘zero expectation’ that Melinda French Gates will step down as co-chair after divorce

White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process

Justice Department probes Bausch Health over marketing for dermatology drugs

Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules

Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments

NIH’s cancer chief, Ned Sharpless, to step down

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence

New details emerge about a U.S. scientist’s obscured role in the ‘CRISPR babies’ scandal

Key lawmaker: ARPA-H won’t be part of NIH

More Democrats flag ‘questions,’ remain uncertain about Biden’s FDA pick, Robert Califf

He founded what became IBM’s most valuable health database. Now, he’s sounding an alarm about patient privacy

The Biden administration used billions in hospital Covid-19 funds to pay drugmakers

With its Alzheimer’s drug in turmoil, Biogen eyes a list of potential acquisitions

A tiny Florida company got more of a scarce Covid therapy than some big hospitals, raising equity questions

Moderna, Amgen among biotech heavyweights pulling out of JPM conference over Covid concerns

‘A multi-decade journey’: Chan Zuckerberg Initiative invests another $3.4 billion to advance scientific tools

Flagship to launch a new startup focused on neurodegenerative conditions, including Parkinson’s

How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day